Arrowhead Pharmaceuticals Inc. ARWR
$75.44
▲ +0.15% 24H
About
Arrowhead Pharmaceuticals is a biotechnology company focused on developing innovative medicines for intractable diseases. The company specializes in RNA interference (RNAi) therapeutics, a cutting-edge approach to treating genetic and metabolic disorders by targeting disease-causing proteins at the molecular level. Its…
SectorHealthcare
ExchangeNASDAQ
IndustryBiotechnology
CountryUnited States
Employees609
TickerARWR
Statistics
Market Cap$10.60B
Revenue (TTM)$829.4M
Net Income-$1.6M
Net Margin-0.2%
EPS$-0.01
P/E47.10
P/S16.78
P/B16.96
EV/EBITDA-48.59
ROE-42.4%
Dividend Yield—
Price$75.44
Data: Twelve Data · Revenue = mcap / P/S